Delivery Order SPE2DB20D1109-SPE2DB23FP61L
- Not listed
- This federal contract award, valued at $2,775.24, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999,...
- This federal contract award, valued at $3,831.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price (FFP) pricing type, and the ultimate completion date is January 14, 2025. The contract covers the provision of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the DLA. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $3,094.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of MULTAQ 400 MG TABLET 60S, a medical product. The contract has an ultimate completion date of January 10, 2024 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, valued at $3,219.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of MULTAQ 400 MG TABLET 60S. The contract has a completion date of February 6, 2024 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- This federal contract award, valued at $5,479.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the pharmaceutical product MULTAQ 400 MG TABLET 60S, with a completion date of December 17, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The $2,227.14 fixed-price delivery order covers the supply of 4563943278 MULTAQ 400 MG TABLET 60S, a cardiovascular medication. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,622.55 Firm Fixed Price delivery order is for the supply of 4555174840 MULTAQ 400 MG TABLET 60S medication. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $25,747.81 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This single-award IDC...
- This federal contract award, valued at $3,356.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,070,998 units of the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract is a Firm Fixed Price Delivery Order with a completion date of September 7, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, as the prime contractor, is a major pharmaceutical...
- This federal contract award, valued at $3,747.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the delivery of 4563018350 - MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 7, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP61LDelivery Order
This federal contract award, valued at $3,028.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a prescription medication, with a completion date of July 27, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc., the parent company of Amerisourcebergen Drug Corp, holds with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 7/26/23 |